The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121422262 12142226 2 F 20111031 20160222 20160303 20160720 EXP IT-MINISAL02-348363 IT-MYLANLABS-2016M1008232 MYLAN 0.00 Y 0.00000 20160720 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121422262 12142226 1 PS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) 80 MG/M2, UNK U U 91540 80 MG/M**2 SOLUTION FOR INJECTION
121422262 12142226 2 C LEVOTHYROXINE. LEVOTHYROXINE 1 0
121422262 12142226 3 C ASPIRINA ASPIRIN 1 0 EFFERVESCENT TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121422262 12142226 1 HER-2 positive gastric cancer
121422262 12142226 2 Product used for unknown indication
121422262 12142226 3 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
121422262 12142226 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121422262 12142226 Abdominal pain upper
121422262 12142226 Ascites
121422262 12142226 Asthenia
121422262 12142226 Haematemesis
121422262 12142226 Haemoglobin decreased
121422262 12142226 Malignant neoplasm progression
121422262 12142226 Oedema peripheral
121422262 12142226 Off label use
121422262 12142226 Platelet count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121422262 12142226 1 20111031 0